Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats

Hypertension

Volumn 55, Issue 3, 2010, Pages 644-651

  Yoshimoto, Misa ^a   Miki, Kenju ^b   Fink, Gregory D ^c   King, Andrew ^c   Osborn, John W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NARA WOMEN'S UNIVERSITY   (Japan)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Hypertension; Lumbar nerve activity; Norepinephrine spillover; Renal nerve activity; Sympathetic

Indexed keywords

ANGIOTENSIN II; NORADRENALIN;

ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CORONARY BLOOD VESSEL; HEMODYNAMICS; HINDLIMB; KIDNEY NERVE; MALE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE; SPINAL ROOT; STEADY STATE; SYMPATHETIC NERVE; SYSTEMATIC REVIEW;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; HEART RATE; HINDLIMB; HYPERTENSION; KIDNEY; LUMBOSACRAL REGION; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTOR AGENTS;

EID: 77149161113     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.145110     Document Type: Article

References (39)

1. Ferrario CM. Neurogenic actions of angiotensin II. Hypertension. 1983; 5(suppl V):V73-V79.
2. Onishi A, Branch RA, Holycross B, Jackson EK. Caffeine enhances the slow pressor response to angiotensin II in rats: evidence for a caffeine-angiotensin II interaction with the sympathetic nervous system. J Clin Invest. 1987;80:13-16.
3. Simon G, Csiky B. Effect of neonatal sympathectomy on the development of structural vascular changes in angiotensin II-treated rats. J Hypertens. 1998;16:77-84.
4. Carroll RG, Lohmeier TE, Brown AJ. Chronic angiotensin infusion decreases renal norepinephrine overflow in conscious dogs. Hypertension (Dallas). 1984;6:675-681.
5. Sato Y, Ogata E, Fujita T. Role of chloride in angiotensin II-induced salt-sensitive hypertension. Hypertension. 1991;18:622-629.
6. Kline RL, Chow K-Y, Mercer PF. Does enhanced sympathetic tone contribute to angiotensin II hypertension in rats? Eur J Pharmacol. 1990;184:109-118.
7. Luft FC. Salt and hypertension: recent advances and perspectives. J Lab Clin Med. 1989;114:215-221.
8. Cox BF, Bishop VS. Neural and humoral mechanisms of angiotensin-dependent hypertension. Am J Physiol Heart Circ Physiol. 1991;261: H1284-H1291.
9. Gorbea-Oppliger VJ, Fink GD. Clonidine reverses the slowly developing hypertension produced by low doses of angiotensin II. Hypertension. 1994;23:844-847.
10. Li Q, Dale WE, Hasser EM, Blaine EW. Acute and chronic angiotensin hypertension: neural and non-neural components, time course, dose dependency. Am J Physiol. 1996;271:R200-R207.
11. King AJ, Novotny M, Swain GM, Fink GD. Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat. Am J Physiol (Reg Int). 2008;4:R1262-R1267.
12. King AJ, Fink GD. Chronic low-dose angiotensin II infusion increases venomotor tone by neurogenic mechanisms. Hypertension. 2006;48: 927-933.
13. Lohmeier TE, Hildbrand DA. Renal nerves promote sodium excretion in angiotensin-induced hypertension. Hypertension. 1998;31:429-434.
14. Burke SL, Head GA. Method for in vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Methods. 2003;127:63-74.
15. Guild SJ, Barrett CJ, McBryde FD, Van Vliet BN, Head GA, Burke SL, Malpas SC. Quantifying sympathetic nerve activity; problems and pitfalls, the need for standardization. Exp Physiol. 2010;95:41-50.
16. Luft FC, Wilcox CS, Unger T, Kuhn R, Demmert G, Rohmeiss P, Ganten D, Sterzel RB. Angiotensin-induced hypertension in the rat: sympathetic nerve activity and prostaglandins. Hypertension. 1989;14:396-403.
17. Barrett CJ, Ramchandra R, Guild SJ, Lala A, Budgett DM, Malpas SC. What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes? Circ Res. 2003;92:1330-1336.
18. Barrett CJ, Guild SJ, Ramchandra R, Malpas SC. Baroreceptor dener-vation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension. 2005;46:168-172.
19. Miki K, Kosho A, Hayashida Y. Method for continuous measurements of renal sympathetic nerve activity and cardiovascular function during exercise in rats. Exp Physiol. 2002;87:33-39.
20. Miki K, Oda M, Kamijyo N, Kawahara K, Yoshimoto M. Lumbar sympathetic nerve activity and hindquarter blood flow during REM sleep in rats. J Physiol. 2004;557:261-271. (Pubitemid 38771650)
21. Miki K, Yoshimoto M, Tanimizu M. Acute shifts of baroreflex control of renal sympathetic nerve activity induced by treadmill exercise in rats. J Physiol. 2003;548:313-322.
22. Yoshimoto M, Wehrwein EA, Novotny M, Swain GM, Kreulen DL, Osborn JW. Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta-1 adrenoceptor blockade in the rat. Am J Physiol Heart Circ Physiol. 2008;295:H2447-H2454.
23. Eisenhofer G. Sympathetic nerve function: assessment by radioisotope dilution analysis. Clin Auton Res. 2005;15:264-283.
24. Brody MJ, Haywood JR, Touw KB. Neural mechanisms in hypertension. Ann Rev Physiol. 1980;42:441-453.
25. Fink GD. Long-term sympathoexcitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension. Clin Exp Pharm and Phys. 1997;24:91-95.
26. King AJ, Novotny M, Swain GM, Fink GD. Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1262-R1267.
27. Osborn JW, Fink GD. Region specific changes in sympathetic nerve activity in AngII-salt hypertension. Exp Physiol. 2010;95:61-68.
28. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep. 2007;9:228-235.
29. Cowley AW Jr, DeClue JW. Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension in dogs. Circ Res. 1976;39:779-787.
30. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension. 2007;50: 547-556.
31. Xu L, Sved AF. Acute sympathoexcitatory action of angiotensin II in conscious baroreceptor-denervated rats. Am J Physiol. 2002;283: R451-R459.
32. Matsukawa T, Gotoh E, Minamisawa K, Kihara M, Ueda S-I, Shionoiri H, Ishii M. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol. 1991;261: R690-R696.
33. Simms AE, Paton JF, Pickering AE, Allen AM. Amplified respiratory-sympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension? J Physiol. 2009;587:597-610.
34. Osborn JW, Guzman PP, King A, Fink G. Celiac ganglionectomy abolishes the chronic vasoconstrictor responses to angiotensin II (AngII) in conscious rats consuming a high salt diet. FASEB J. 2007;21:899-1893
35. Fukiyama K. Central action of angiotensin and hypertension-increased central vasomotor outflow by angiotensin. Jpn Circ J. 1972;36:599-602.
36. Morrison SF. Differential control of sympathetic outflow. Am J Physiol. 2001;281:R683-R696.
37. McMullan S, Goodchild AK, Pilowsky PM. Circulating angiotensin II attenuates sympathetic baroreflex by reducing barosensitivity of medullary cardiovascular neurones in the rat. J Physiol. 2007;582: 711-722.
38. Esler M. Sympathetic activity in experimental and human hypertension. In: Bulpitt CJ, ed. Pathophysiology of Hypertension. Vol 17. Amsterdam, the Netherlands: Elsevier Science;1997:628-673.
39. Guyenet PG. The sympathetic control of blood pressure [Review]. Nat Rev Neurosci. 2006;7:335-346.